Tumor vascular targeting therapy with viral vectors.

Abstract:

:Tumor angiogenesis is crucial for the progression and metastasis of cancer. The vasculature of tumor tissue is different from normal vasculature. Therefore, tumor vascular targeting therapy could represent an effective therapeutic strategy with which to suppress both primary tumor growth and tumor metastasis. The use of viral vectors for tumor vascular targeting therapy is a promising strategy based on the unique properties of viral vectors. In order to circumvent the potential problems of antiviral neutralizing antibodies, poor access to extravascular tumor tissue, and toxicities to normal tissue, viral vectors need to be modified to target the tumor endothelial cells. Viral vectors that could be used for tumor vascular targeting therapy include adenoviral vectors, adeno-associated viral vectors, retroviral vectors, lentiviral vectors, measles virus, and herpes simplex viral vectors. In this review, we will summarize the strategies available for targeting viral vectors for tumor vascular targeting therapy.

journal_name

Blood

journal_title

Blood

authors

Liu Y,Deisseroth A

doi

10.1182/blood-2005-10-4114

subject

Has Abstract

pub_date

2006-04-15 00:00:00

pages

3027-33

issue

8

eissn

0006-4971

issn

1528-0020

pii

2005-10-4114

journal_volume

107

pub_type

杂志文章,评审

相关文献

BLOOD文献大全
  • Induction of fetal hemoglobin through enhanced translation efficiency of γ-globin mRNA.

    abstract::Fetal hemoglobin (HbF) induction can ameliorate the clinical severity of sickle cell disease and β-thalassemia. We previously reported that activation of the eukaryotic initiation factor 2α (eIF2α) stress pathway increased HbF through a posttranscriptional mechanism. In this study, we explored the underlying means by ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-03-564302

    authors: Hahn CK,Lowrey CH

    更新日期:2014-10-23 00:00:00

  • High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia.

    abstract::By using an enzyme-linked immunosorbent assay, the presence of the soluble form of the interleukin-2 receptor (sIL-2R) was evaluated in the peripheral blood of 54 patients with B cell chronic lymphocytic leukemia (B-CLL). Serum levels of sIL-2R were correlated with clinical features, relevant hematologic and immunolog...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Semenzato G,Foa R,Agostini C,Zambello R,Trentin L,Vinante F,Benedetti F,Chilosi M,Pizzolo G

    更新日期:1987-08-01 00:00:00

  • Effects of interleukin-3 and erythropoietin on in vivo erythropoiesis and F-cell formation in primates.

    abstract::To test the in vivo cooperativity between interleukin-3 (IL-3) and erythropoietin (Epo) in stimulating erythropoiesis and hemoglobin F (HbF) production in primates, we administered recombinant human IL-3 and recombinant human Epo to baboons and macaques. The effect of these treatments was assessed by serial bone marro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Umemura T,al-Khatti A,Donahue RE,Papayannopoulou T,Stamatoyannopoulos G

    更新日期:1989-10-01 00:00:00

  • Murine malaria decreases hemopoietic stem cells.

    abstract::The causes of anemia and immunosuppression, major outcomes of malaria, are not well established. This study was undertaken to investigate whether erythropoietin (EP) production is adequate and whether the hemopoietic stem cells (CFU-S) were affected during the course of infection. Groups of female Balb/c mice infected...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Silverman PH,Schooley JC,Mahlmann LJ

    更新日期:1987-02-01 00:00:00

  • Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies.

    abstract::Heparin is a widely used anticoagulant. Because of its negative charge, it forms complexes with positively charged platelet factor 4 (PF4). This can induce anti-PF4/heparin IgG Abs. Resulting immune complexes activate platelets, leading to the prothrombotic adverse drug reaction heparin-induced thrombocytopenia (HIT)....

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-05-353391

    authors: Krauel K,Hackbarth C,Fürll B,Greinacher A

    更新日期:2012-02-02 00:00:00

  • The embryonic origins of erythropoiesis in mammals.

    abstract::Erythroid (red blood) cells are the first cell type to be specified in the postimplantation mammalian embryo and serve highly specialized, essential functions throughout gestation and postnatal life. The existence of 2 developmentally and morphologically distinct erythroid lineages, primitive (embryonic) and definitiv...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2012-01-153486

    authors: Baron MH,Isern J,Fraser ST

    更新日期:2012-05-24 00:00:00

  • Clonal evolution in atypical chronic granulocytic leukemia: a non-Philadelphia translocation.

    abstract::Hemopoietic cells in chronic granulocytic leukemia (CGL) frequently contain a chromosome translocation involving chromosome 22 and another autosome, usually number 9. The translocated chromosome 22 is known as the Philadelphia (Ph) chromosome. The appearance of a second Ph chromosome is the most common cytogenetic abn...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bagby GC Jr,Kaiser-McCaw B,Hecht F,Koler RD,Linman JW

    更新日期:1978-06-01 00:00:00

  • Human platelet cGI-PDE: expression in yeast and localization of the catalytic domain by deletion mutagenesis.

    abstract::Cyclic adenosine monophosphate (cAMP) is an important modulator of platelet responses to agonists. Cyclic nucleotide phosphodiesterase (PDE) controls intracellular cAMP concentrations by hydrolyzing it to AMP. The major PDE activity in platelets is PDE3A (cyclic guanosine monophosphate [cGMP]-inhibited PDE). To obtain...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cheung PP,Xu H,McLaughlin MM,Ghazaleh FA,Livi GP,Colman RW

    更新日期:1996-08-15 00:00:00

  • In vivo generation of human dendritic cell subsets by Flt3 ligand.

    abstract::Dendritic cells (DCs) represent a family of ontogenically distinct leukocytes involved in immune response regulation. The ability of DCs to stimulate T-cell immunity has led to their use as vectors for immunotherapy vaccines. However, it is unclear whether and to what degree in vitro-generated DCs are representative o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Maraskovsky E,Daro E,Roux E,Teepe M,Maliszewski CR,Hoek J,Caron D,Lebsack ME,McKenna HJ

    更新日期:2000-08-01 00:00:00

  • Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells.

    abstract::BR3, which is expressed on all mature B cells, is a specific receptor for the B-cell survival and maturation factor BAFF (B-cell-activating factor belonging to the tumor necrosis factor [TNF] family). In order to investigate the consequences of targeting BR3 in murine models and to assess the potential of BR3 antibodi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-03-011031

    authors: Lee CV,Hymowitz SG,Wallweber HJ,Gordon NC,Billeci KL,Tsai SP,Compaan DM,Yin J,Gong Q,Kelley RF,DeForge LE,Martin F,Starovasnik MA,Fuh G

    更新日期:2006-11-01 00:00:00

  • Activation of Stat-3 is involved in the induction of apoptosis after ligation of major histocompatibility complex class I molecules on human Jurkat T cells.

    abstract::Activation of Janus tyrosine kinases (Jak) and Signal transducers and activators of transcription (Stat) after ligation of major histocompatibility complex class I (MHC-I) was explored in Jurkat T cells. Cross-linking of MHC-I mediated tyrosine phosphorylation of Tyk2, but not Jak1, Jak2, and Jak3. In addition, the tr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Skov S,Nielsen M,Bregenholt S,Odum N,Claesson MH

    更新日期:1998-05-15 00:00:00

  • Vitamin C inhibits FAS-induced apoptosis in monocytes and U937 cells.

    abstract::The FAS receptor-FAS ligand system is a key apoptotic pathway for cells of the immune system. Ligation of the FAS-receptor (CD95) induces apoptosis by activation of pro-caspase-8 followed by downstream events, including an increase in reactive oxygen species (ROS) and the release of proapoptotic factors from the mitoc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-11-3559

    authors: Perez-Cruz I,Carcamo JM,Golde DW

    更新日期:2003-07-01 00:00:00

  • Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion.

    abstract::In utero hematopoietic stem cell transplantation (IUHSCTx) can achieve mixed hematopoietic chimerism and donor-specific tolerance without cytoreductive conditioning or immunosuppression. The primary limitation to the clinical application of IUHSCTx has been minimal donor cell engraftment, well below therapeutic levels...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-01-0016

    authors: Hayashi S,Peranteau WH,Shaaban AF,Flake AW

    更新日期:2002-08-01 00:00:00

  • Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells.

    abstract::Donor alloreactive CD4(+) T cells are important to the pathogenesis of chronic graft-versus-host disease (cGVHD), but specific subsets of CD4(+) T cells responsible for GVHD have not been defined. We hypothesized that cGVHD might be associated with a preponderance of CD4(+) effector memory cells (CCR7(-)/CD62L(low), C...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-09-3286

    authors: Yamashita K,Choi U,Woltz PC,Foster SF,Sneller MC,Hakim FT,Fowler DH,Bishop MR,Pavletic SZ,Tamari M,Castro K,Barrett AJ,Childs RW,Illei GG,Leitman SF,Malech HL,Horwitz ME

    更新日期:2004-05-15 00:00:00

  • Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study.

    abstract::The combination of imatinib with chemotherapy has been recently reported as very promising in patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL). During 2004 and 2005, 45 patients with newly diagnosed Ph+ ALL were treated in the Group for Research on Adult Acute Lymphoblastic Leuke...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2006-03-011908

    authors: de Labarthe A,Rousselot P,Huguet-Rigal F,Delabesse E,Witz F,Maury S,Réa D,Cayuela JM,Vekemans MC,Reman O,Buzyn A,Pigneux A,Escoffre M,Chalandon Y,MacIntyre E,Lhéritier V,Vernant JP,Thomas X,Ifrah N,Dombret H,Group

    更新日期:2007-02-15 00:00:00

  • Chemical genomic screening reveals synergism between parthenolide and inhibitors of the PI-3 kinase and mTOR pathways.

    abstract::We have previously shown that the plant-derived compound parthenolide (PTL) can impair the survival and leukemogenic activity of primary human acute myeloid leukemia (AML) stem cells. However, despite the activity of this agent, PTL also induces cellular protective responses that likely function to reduce its overall ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-04-278044

    authors: Hassane DC,Sen S,Minhajuddin M,Rossi RM,Corbett CA,Balys M,Wei L,Crooks PA,Guzman ML,Jordan CT

    更新日期:2010-12-23 00:00:00

  • A crucial role for the homeodomain transcription factor Hhex in lymphopoiesis.

    abstract::The hematopoietically expressed homeobox gene, Hhex, is a transcription factor that is important for development of definitive hematopoietic stem cells (HSCs) and B cells, and that causes T-cell leukemia when overexpressed. Here, we have used an Hhex inducible knockout mouse model to study the role of Hhex in adult he...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-06-579813

    authors: Jackson JT,Nasa C,Shi W,Huntington ND,Bogue CW,Alexander WS,McCormack MP

    更新日期:2015-01-29 00:00:00

  • SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells.

    abstract::Chemokine stromal derived factor 1 (SDF-1) is involved in trafficking of hematopoietic stem cells (HSCs) from the bone marrow (BM) to peripheral blood (PB) and has been found to enhance postischemia angiogenesis. This study was aimed at investigating whether SDF-1 plays a role in differentiation of BM-derived c-kit(+)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-12-4423

    authors: De Falco E,Porcelli D,Torella AR,Straino S,Iachininoto MG,Orlandi A,Truffa S,Biglioli P,Napolitano M,Capogrossi MC,Pesce M

    更新日期:2004-12-01 00:00:00

  • Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice.

    abstract::Stable gene replacement by in vivo administration of lentiviral vectors (LVs) has therapeutic potential for metabolic disorders and other systemic diseases. We studied the expression of intracellular and secreted proteins by LVs in immunocompetent mice. Liver, spleen, and bone marrow cells were efficiently transduced....

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-09-3217

    authors: Follenzi A,Battaglia M,Lombardo A,Annoni A,Roncarolo MG,Naldini L

    更新日期:2004-05-15 00:00:00

  • CD33 expression and P-glycoprotein-mediated drug efflux inversely correlate and predict clinical outcome in patients with acute myeloid leukemia treated with gemtuzumab ozogamicin monotherapy.

    abstract::Gemtuzumab ozogamicin (GO) contains an anti-CD33 antibody to facilitate uptake of a toxic calicheamicin-gamma(1) derivative. While recent in vitro data demonstrated a quantitative relationship between CD33 expression and GO cytotoxicity, previous correlative studies failed to identify a significant association between...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-09-047399

    authors: Walter RB,Gooley TA,van der Velden VH,Loken MR,van Dongen JJ,Flowers DA,Bernstein ID,Appelbaum FR

    更新日期:2007-05-15 00:00:00

  • FLT3/FLK2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units.

    abstract::The effect of FLT3/FLK2 ligand (FL) on the growth of primitive hematopoietic cells was investigated using ThyloSca1+ stem cells. FL was observed to interact with a variety of factors to initiate colony formation by stem cells. When stem cells were stimulated in liquid culture with FL plus interleukin (IL)-3, IL-6, gra...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hudak S,Hunte B,Culpepper J,Menon S,Hannum C,Thompson-Snipes L,Rennick D

    更新日期:1995-05-15 00:00:00

  • Early onset of immunoglobulin heavy chain gene rearrangements in normal human bone marrow CD34+ cells.

    abstract::To characterize early B-cell precursors in humans, we correlated immunoglobulin heavy chain (IgH) gene rearrangement status with the CD34, CD19, and CD10 cell surface markers. Highly purified adult bone marrow (BM) cell fractions were obtained by two successive rounds of flow cytometric cell sorting, and IgH rearrange...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Davi F,Faili A,Gritti C,Blanc C,Laurent C,Sutton L,Schmitt C,Merle-Béral H

    更新日期:1997-11-15 00:00:00

  • Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia.

    abstract::Cumulative evidence indicates that MYC, one of the major downstream effectors of NOTCH1, is a critical component of T-cell acute lymphoblastic leukemia (T-ALL) oncogenesis and a potential candidate for targeted therapy. However, MYC is a complex oncogene, involving both fine protein dosage and cell-context dependency,...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-02-336842

    authors: Bonnet M,Loosveld M,Montpellier B,Navarro JM,Quilichini B,Picard C,Di Cristofaro J,Bagnis C,Fossat C,Hernandez L,Mamessier E,Roulland S,Morgado E,Formisano-Tréziny C,Dik WA,Langerak AW,Prebet T,Vey N,Michel G,Gabert

    更新日期:2011-06-16 00:00:00

  • Detection of carriers of the autosomal form of chronic granulomatous disease.

    abstract::The NADPH:O2 oxidoreductase catalyzing the respiratory burst in activated phagocytes from healthy individuals is not operative in phagocytes from patients with chronic granulomatous disease (CGD). In a microscopic slide test using the dye nitroblue tetrazolium (NBT), carriers of X-linked CGD can be recognized by a mos...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Verhoeven AJ,van Schaik ML,Roos D,Weening RS

    更新日期:1988-02-01 00:00:00

  • Transient response to imatinib mesylate (STI571) in a patient with the ETV6-ABL t(9;12) translocation.

    abstract::We report the transient response of a patient with the ETV6-ABL fusion gene to imatinib mesylate (STI571). A 38-year-old man was referred with an erroneous diagnosis of Philadelphia-positive chronic myeloid leukemia in blastic transformation for treatment with the ABL tyrosine kinase inhibitor, STI571. Further investi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.9.3465

    authors: O'Brien SG,Vieira SA,Connors S,Bown N,Chang J,Capdeville R,Melo JV

    更新日期:2002-05-01 00:00:00

  • Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry.

    abstract::Acquired chromosomal anomalies (most commonly translocations) in lymphoma and leukemia usually result in either activation of a quiescent gene (by means of immunoglobulin or T-cell-receptor promotors) and expression of an intact protein product, or creation of a fusion gene encoding a chimeric protein. This review sum...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood.v99.2.409

    authors: Falini B,Mason DY

    更新日期:2002-01-15 00:00:00

  • Plasma microparticles of sickle patients during crisis or taking hydroxyurea modify endothelium inflammatory properties.

    abstract::Microparticles (MPs) are submicron extracellular vesicles exposing phosphatidylserine (PS), detected at high concentration in the circulation of sickle cell anemia (SS) patients. Several groups studied the biological effects of MPs generated ex vivo. Here, we analyzed for the first time the impact of circulating MPs o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020004853

    authors: Garnier Y,Ferdinand S,Garnier M,Cita KC,Hierso R,Claes A,Connes P,Hardy-Dessources MD,Lapouméroulie C,Lemonne N,Etienne-Julan M,El Nemer W,Romana M

    更新日期:2020-07-09 00:00:00

  • Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders.

    abstract::An acquired gain-of-function mutation in the Janus kinase 2 (JAK2-V617F) is frequently found in patients with myeloproliferative disorders (MPDs). To test the hypothesis that JAK2-V617F is the disease-initiating mutation, we examined whether all cells of clonal origin carry the JAK2-V617F mutation. Using allele-specif...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2005-11-009605

    authors: Kralovics R,Teo SS,Li S,Theocharides A,Buser AS,Tichelli A,Skoda RC

    更新日期:2006-08-15 00:00:00

  • Extraembryonic expression of EPCR is essential for embryonic viability.

    abstract::The endothelial cell protein C receptor (EPCR) augments protein C activation by the thrombin-thrombomodulin complex. Deletion of the EPCR gene (Procr) in mice leads to embryonic lethality before embryonic day 10 (E10.0). EPCR is detected in the giant trophoblast cells at the feto-maternal boundary from E7.5 and weakly...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-01-0406

    authors: Li W,Zheng X,Gu JM,Ferrell GL,Brady M,Esmon NL,Esmon CT

    更新日期:2005-10-15 00:00:00

  • Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis.

    abstract::We studied the impact of driver mutations of JAK2, CALR, (calreticulin gene) or MPL on clinical course, leukemic transformation, and survival of patients with primary myelofibrosis (PMF). Of the 617 subjects studied, 399 (64.7%) carried JAK2 (V617F), 140 (22.7%) had a CALR exon 9 indel, 25 (4.0%) carried an MPL (W515)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-05-578435

    authors: Rumi E,Pietra D,Pascutto C,Guglielmelli P,Martínez-Trillos A,Casetti I,Colomer D,Pieri L,Pratcorona M,Rotunno G,Sant'Antonio E,Bellini M,Cavalloni C,Mannarelli C,Milanesi C,Boveri E,Ferretti V,Astori C,Rosti V,Cerva

    更新日期:2014-08-14 00:00:00